Safety and Efficacy of Ceftaroline in Neonates With Staphylococcal Late-onset Sepsis: A Case Series Analysis - Archive ouverte HAL Access content directly
Journal Articles Pediatric Infectious Disease Journal Year : 2023

Safety and Efficacy of Ceftaroline in Neonates With Staphylococcal Late-onset Sepsis: A Case Series Analysis

Abstract

Treatment of late-onset neonatal staphylococcal sepsis is sometimes challenging with feared side effects of vancomycin, increasing minimal inhibitory concentrations and questions about catheter management. In case of failure, ceftaroline was administered as a compassionate treatment in 16 infants (gestational age of less than 32 weeks and less than 28 postnatal days), whose first-line treatment failed. We report 11 successes and no severe adverse drug reactions. Larger data are required to confirm these encouraging results.
Fichier principal
Vignette du fichier
Callies et al 2023-Safety and Efficacy of Ceftaroline in Neonates With Staphylococcal Late Onset Sepsis.pdf (680.58 Ko) Télécharger le fichier
Origin : Files produced by the author(s)
Licence : CC BY NC - Attribution - NonCommercial

Dates and versions

hal-04197965 , version 1 (16-11-2023)

Identifiers

Cite

Arnaud Callies, Lise Martin-Perceval, Lise Crémet, Lilas Gély, Anne Lise Ruellan, et al.. Safety and Efficacy of Ceftaroline in Neonates With Staphylococcal Late-onset Sepsis: A Case Series Analysis. Pediatric Infectious Disease Journal, 2023, 42 (10), pp.888-892. ⟨10.1097/INF.0000000000004023⟩. ⟨hal-04197965⟩
80 View
36 Download

Altmetric

Share

Gmail Facebook X LinkedIn More